Table 2.
Summary of the treatment
| Baseline treatment | Patients (n) | Ratio (%) |
|---|---|---|
| Registered department | ||
| Outpatient | 2,824 | 75.07 |
| Inpatient | 182 | 4.84 |
| Both out- and inpatient | 755 | 20.07 |
| Unknown or not recorded | 1 | 0.03 |
| Mean daily dose of nalfurafine (µg) | ||
| 2.5 | 3,287 | 87.37 |
| >2.5 to <5 | 436 | 11.59 |
| 5.0 | 28 | 0.74 |
| >5.0 | 0 | 0.00 |
| Unknown or not recorded | 11 | 0.29 |
| Total dose of nalfurafine (µg) | ||
| ≤105 | 559 | 14.86 |
| >105 to ≤210 | 247 | 6.57 |
| >210 to ≤420 | 424 | 11.27 |
| >420 to ≤840 | 380 | 10.10 |
| >840 | 2,133 | 56.70 |
| Unknown or not recorded | 19 | 0.51 |
| Treatment duration (number of days nalfurafine was given) | ||
| ≤42 | 564 | 14.99 |
| >42 to ≤84 | 256 | 6.80 |
| >84 to ≤168 | 430 | 11.43 |
| >168 to ≤365 | 518 | 13.77 |
| >365 | 1,977 | 52.55 |
| Unknown or not recorded | 17 | 0.45 |
| Frequency of dialysis (n/week) | ||
| <2 | 22 | 0.58 |
| 2 | 82 | 2.18 |
| >2 to <3 | 95 | 2.53 |
| 3 | 3,546 | 94.26 |
| >3 to <4 | 6 | 0.16 |
| 4 | 5 | 0.13 |
| >4 | 0 | 0.00 |
| Unknown or not recorded | 6 | 0.16 |
| Duration of dialysis (hours) | ||
| ≤3 | 434 | 11.54 |
| >3 to ≤4 | 2,928 | 77.83 |
| >4 to ≤5 | 368 | 9.78 |
| >5 | 23 | 0.61 |
| Unknown or not recorded | 9 | 0.24 |
| Time to dialysis after nalfurafine administration (hours) | ||
| ≤4 | 94 | 2.50 |
| >4 to ≤8 | 39 | 1.04 |
| >8 to ≤12 | 972 | 25.84 |
| >12 to ≤16 | 1,779 | 47.29 |
| >16 to ≤20 | 723 | 19.22 |
| >20 to ≤24 | 125 | 3.32 |
| >24 | 1 | 0.03 |
| Unknown or not recorded | 29 | 0.77 |
| Previous treatment against pruritus (yes/no) | ||
| No | 684 | 18.18 |
| Yes | 3,067 | 81.53 |
| Unknown or not recorded | 11 | 0.29 |
| Concomitant treatment against pruritus (yes/no) | ||
| No | 790 | 21.00 |
| Yes | 2,965 | 78.81 |
| Unknown or not recorded | 7 | 0.19 |
| Concomitant treatment (yes/no) | ||
| No | 87 | 2.31 |
| Yes | 3,675 | 97.69 |
| Unknown or not recorded | 0 | 0.00 |